These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22728860)

  • 1. Botulinum toxin-A use in paediatric hypertonia: Canadian practice patterns.
    Fehlings D; Narayanan U; Andersen J; Beauchamp R; Gorter JW; Kawamura A; Kiefer G; Mason M; McCormick A; Mesterman R; Switzer L; Watt J
    Can J Neurol Sci; 2012 Jul; 39(4):508-15. PubMed ID: 22728860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin: Techniques Within Pediatric Physiatry.
    Paulson A; Zigler CK; Houtrow A; Pruitt D
    PM R; 2019 Jan; 11(1):38-44. PubMed ID: 29964211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
    Nguyen L; Mesterman R; Gorter JW
    BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.
    Paget SP; Swinney CM; Burton KLO; Bau K; O'Flaherty SJ
    Dev Med Child Neurol; 2018 Nov; 60(11):1172-1177. PubMed ID: 30146721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice Patterns of Physicians Using Adjunct Therapies with Botulinum Toxin Injection for Spasticity: A Canadian Multicenter Cross-Sectional Survey.
    Ip AH; Phadke CP; Boulias C; Ismail F; Mills PB
    PM R; 2021 Apr; 13(4):372-378. PubMed ID: 32578339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for post-stroke spastic hypertonia: a review of its efficacy and application in clinical practice.
    Francisco GE
    Ann Acad Med Singap; 2007 Jan; 36(1):22-30. PubMed ID: 17285183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best clinical practice in botulinum toxin treatment for children with cerebral palsy.
    Strobl W; Theologis T; Brunner R; Kocer S; Viehweger E; Pascual-Pascual I; Placzek R
    Toxins (Basel); 2015 May; 7(5):1629-48. PubMed ID: 25969944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence.
    Grosse J; Kramer G; Stöhrer M
    Eur Urol; 2005 May; 47(5):653-9. PubMed ID: 15826758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A injection in the treatment of chronic pelvic pain with hypertonic pelvic floor in women: Treatment techniques and results.
    Chuang FC; Yang TH; Kuo HC
    Low Urin Tract Symptoms; 2021 Jan; 13(1):5-12. PubMed ID: 32654386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin Type A Injections as Monotherapy for Upper Limb Essential Tremor Using Kinematics.
    Samotus O; Kumar N; Rizek P; Jog M
    Can J Neurol Sci; 2018 Jan; 45(1):11-22. PubMed ID: 29157315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common practices in botulinum toxin injection for spasmodic dysphonia treatment: A national survey.
    Shoffel-Havakuk H; Rosow DE; Lava CX; Hapner ER; Johns MM
    Laryngoscope; 2019 Jul; 129(7):1650-1656. PubMed ID: 30582627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A and cervical dystonia: a seven-year follow-up.
    Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC
    Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults.
    Richardson D; Sheean G; Werring D; Desai M; Edwards S; Greenwood R; Thompson A
    J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):499-506. PubMed ID: 10990511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical dystonia: clinical and therapeutic features in 85 patients.
    Camargo CH; Teive HA; Becker N; Baran MH; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 2008 Mar; 66(1):15-21. PubMed ID: 18392407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement.
    Fehlings D; Novak I; Berweck S; Hoare B; Stott NS; Russo RN;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():38-56. PubMed ID: 20633178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.